COLL
Collegium Pharmaceutical Inc
NASDAQ: COLL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$37.80
-3.89% today
Updated 2026-05-08
Market cap
$1.11B
P/E ratio
19.84
P/S ratio
1.43x
EPS (TTM)
$1.73
Dividend yield
—
52W range
$27 – $51
Volume
0.6M
WallStSmart proprietary scores
65
out of 100
Grade: B
Buy
Investment rating
8.0
Growth
A5.0
Quality
C+7.5
Profitability
B+7.0
Valuation
B+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$54.17
+43.31%
12-Month target
$41.56
+9.95%
Intrinsic (DCF)
$416.48
Margin of safety
+89.16%
2 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ ROE 23.70% — strong efficiency
+ Free cash flow $122.36M — positive
+ Revenue growth 12.90% QoQ
+ 89.16% below intrinsic value
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $463.93M | $566.77M | $631.45M | $780.57M | $780.57M |
| Net income | $-25.00M | $48.16M | $69.19M | $62.87M | $16.96M |
| EPS | — | — | — | — | $1.73 |
| Free cash flow | $122.61M | $274.29M | $203.33M | $327.58M | $122.36M |
| Profit margin | -5.39% | 8.50% | 10.96% | 8.05% | 8.05% |
Peer comparison
Smart narrative
Collegium Pharmaceutical Inc trades at $37.80. representing a P/E of 19.84x trailing earnings. Our Smart Value Score of 65/100 indicates the stock is good. TTM revenue stands at $780.57M. with profit margins at 8.05%. Our DCF model estimates intrinsic value at $416.48.
Frequently asked questions
What is Collegium Pharmaceutical Inc's stock price?
Collegium Pharmaceutical Inc (COLL) trades at $37.80.
Is Collegium Pharmaceutical Inc overvalued?
Smart Value Score 65/100 (Grade B, Buy). DCF value $416.48.
What is the price target of Collegium Pharmaceutical Inc (COLL)?
The analyst target price is $54.17, representing +43.3% upside from the current price of $37.80.
What is the intrinsic value of Collegium Pharmaceutical Inc (COLL)?
Based on our DCF model, intrinsic value is $416.48, a +89.2% margin of safety versus $37.80.
What is Collegium Pharmaceutical Inc's revenue?
TTM revenue is $780.57M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.43x
ROE23.70%
Beta0.76
50D MA$35.86
200D MA$39.39
Shares out0.03B
Float0.03B
Short ratio—
Avg volume0.6M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—